Canonical | a thrombin mediated activation of PAR1 |
Noncanonical | protease that is distinct from thrombin that generates a unique tethered ligand sequence in PAR1 |
HMGA2 | High-mobility group AT-hook2 nuclear protein-a member of the superfamily of non-histone chromatin family that regulate gene expression through remodeling of the chromatin |
EMT | epithelial-mesenchymal transition |
NF-κB | nuclear factor-kappaB |
miR-17 | microRNA |
E-cadherin | type-1 transmembrane glycoprotein |
Twist | basic helix-loop-helix transcription factor |
Hippo pathway | kinase cascade especially important in development |
TAZ | transcription regulator 1 |
Akt | protein kinase B |
Vimentin | structural protein |
PH | plekstrin homology |
Etk | tyrosine kinase |
ARRDC3 | Arrestin domain containing 3β-arrestin protein |
JNK | Jun-N-terminal kinase |
ALEX1 | a tumor-suppressor member of the armadillo family |
Tpl2 | tumor progression locus 2 kinase |
Rac1 | Rho GTPase |
PLD | phospholipase D |
RhoA,Rap1A | Ras related GTPases |
ERK | the extracellular signal-regulated kinase |
VEGF | vascular endothelial growth factor |
CXCR1/2 | C-X-C chemokine receptors 1 and 2 |
ROS | reactive oxygen species |
MMP-1 | matrix metalloproteinase 1 |
PAR1 | protease activated receptor 1 |
Human MCF7-PAR1 (clone N55) | stable high PAR1 expressing MCF7 clone 55 (note MCF-7 cells don not express PAR1) |
PAR1-null | lack of PAR1 expression |
Human MCF7-PAR1 (R310E) | stable cell line expression PAR1 with an R310E mutation that results in high expression of a PAR1 non-signaling receptor |
NCR nu/nu mice | immuno-deficient mouse model |
MMP-1 Inh | FN439 matrix metalloprotease 1 inhibitor |
vWF | von Willebrand Factor |
Human MDA-MB-231 | PAR1 expressing breast cancer cell line |
PZ-128 | also known as P1pal-7 is the PAR1 antagonist pepducin |
metastatic incidence | appearance of macroscopic tumor nodules at the surface of lung or using histologic analysis of lung sections |
tumor incidence | number of tumors formed after subcutaneous implantation into mammary fat pads |
TUNEL | terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling |
A549 | human PAR1 expressing lung adenocarcinoma |
LLC1 | mouse Lewis lung carcinoma |
LLC1-shPAR1 | a short hairpin-RNA that silenced PAR1 expression |
LLC1-shControl | control (shLuciferase) |
MMP1a-KO | MMP1 knockout mouse |
OVCAR-4 and SKOV-3 | Human ovarian cell lines |
Ascites formation | production of large volume of fluid in the peritoneal cavity |
Intraperitoneal cavity | space between the abdominal wall and the surrounding interanal organs |
Peritoneal carcinomatosis | mice were injected into the peritoneal cavity with ovarian cancer cells |
FAK ERK1/2 |
focal adhesion kinase extracellular signal-regulated kinase 1 and 2 |